Omega Therapeutics, Inc.

    Omega Therapeutics, Inc.

    NNASDAQ:OMGA
    0.02
    USD
    +0.01
    (+50.44%)
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    - -
    - -
    0.01
    0.04
    0.06
    0.15
    Basic EPS, GAAP
    -0.69
    -0.95
    -3.05
    -2.14
    -1.8
    -1.33
    Free Cash Flow per Basic Share
    -0.64
    -0.9
    -2.64
    -2.09
    -1.75
    -1.05
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -1.42
    -2.13
    -6
    -4.95
    -6.19
    -7.03
    Tangible Book Value per Share
    -1.39
    -2.08
    8.95
    2.21
    1.07
    0.21
    Basic Weighted Avg Shares
    26
    31
    22
    48
    54
    55
    Sales/Revenue/Turnover
    - -
    - -
    - -
    2
    3
    8
    Operating Margin (%)
    - -
    - -
    -45,855.56
    -4,957.36
    -3,240.5
    -916
    Depreciation Expense
    1
    1
    1
    5
    7
    7
    Net Income, GAAP
    -18
    -29
    -68
    -103
    -97
    -73
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    -47,416.67
    -4,954.22
    -3,148.93
    -902.93
    Working Capital
    - -
    16
    217
    116
    63
    15
    LT Debt
    12
    9
    20
    18
    113
    112
    Total Equity
    -36
    -65
    201
    106
    58
    12
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    16
    16
    16
    LT Borrowings
    14
    13
    12
    LT Finance Leases
    98
    98
    101
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    55
    55
    55
    Market Capitalization
    201
    114
    67

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    71
    56
    39
    Cash, Cash Equivalents & STI
    60
    46
    30
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    25
    26
    24
    Payables & Accruals
    4
    4
    3
    ST Debt
    16
    16
    16
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -45.25%
    Free Cash Flow
    - -
    - -
    -5.52%
    Net Income, GAAP
    - -
    - -
    -5.13%
    Sales/Revenue/Turnover
    - -
    - -
    49.25%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    1
    1
    2
    2023
    1
    1
    1
    1
    3
    2024
    2
    2
    3
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.42
    -0.54
    -0.54
    -0.64
    -2.14
    2023
    -0.5
    -0.54
    -0.4
    - -
    -1.8
    2024
    -0.36
    -0.3
    -0.3
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Omega Pacific Commences Drill Program at Williams Property

    • Omega Pacific Williams Property Exploration Program Update

    • Omega Pacific Outlines 2026 Exploration Program at the Williams Property

    • Omega Pacific Closes First Tranche of Non-Brokered Private Placement

    • Omega Pacific Clarifies Size of Previously Announced Private Placement

    • Omega Pacific Announces Non-Brokered Private Placement

    • Omega Pacific Acquires 100% of Williams Property

    • Omega Pacific Closes Non-Brokered Private Placement

    • Omega Pacific Closes First Tranche of Offering

    • Omega Pacific Announces Private Placement

    • Omega Pacific Outlines 2025 Exploration Program in the Revitalized Toodoggone District

    • Omega Pacific Reports Its Final Drill Hole Yielding Multiple Zones of Mineralization at Its Williams Property

    • Omega Pacific Announces 2024 Work Program Results From Its Lekcin Property

    • Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates

    • Omega Pacific Earns 51% Interest in Williams Property

    • Omega Pacific Adds John Williamson as Independent Director

    • Omega Pacific Extends Historical Hole WM22-02 Mineralization to 2.16 G/t Au Over 96.92 Metres

    • Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

    • Omega Pacific Issues Common Shares for Three Additional Claims in the Golden Horseshoe Area in British Columbia

    • Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications